NKX3.1 Antibodies

Find the right product for your experiment. Filter by application, check species reactivity, enquire directly with suppliers.

5 products from 1 supplier.

Applications
WB
Reactivity
Human
HostMouse
ClonalityMonoclonal

Pricing on enquiry

View datasheet on OriGene
Applications
IHCWB
Reactivity
Human
HostMouse
ClonalityMonoclonal

Pricing on enquiry

View datasheet on OriGene
Applications
IHC
Reactivity
Human
HostMouse
ClonalityMonoclonal

Pricing on enquiry

View datasheet on OriGene
Applications
IHC
Reactivity
Human
HostMouse
ClonalityMonoclonal

Pricing on enquiry

View datasheet on OriGene
Applications
IFIHCWB
Reactivity
Human
HostMouse
ClonalityMonoclonal

Pricing on enquiry

View datasheet on OriGene

Frequently Asked Questions

What is NKX3.1?

Homeobox protein Nkx-3.1, also known as NKX3-1, NKX3, BAPX2, NKX3A and NKX3.1 is a protein that in humans is encoded by the NKX3-1 gene located on chromosome 8p. NKX3-1 is a prostatic tumor suppressor gene.

Source: Wikipedia

What diseases are associated with NKX3.1?

NKX3.1 has been associated with prostate tumor progression. This gene encodes a homeobox-containing transcription factor. This transcription factor functions as a negative regulator of epithelial cell growth in prostate tissue. Aberrant expression of this gene

Source: NCBI Gene 4824

Which NKX3.1 antibody is most cited in research?

Proteintech 60004-1-Ig (GAPDH antibody) with 705 RRID-verified research citations.

Source: Antibody Registry (RRID)

What applications are NKX3.1 antibodies used for?

NKX3.1 antibodies are commonly validated for WB, IP, IHC, IF, FC, ELISA, ChIP. Application data is sourced from supplier specifications and verified through the Antibody Registry.

Source: Antibody Registry (RRID)

PubMed: NKX3.1 antibodyAntibody Registry

Need a NKX3.1 antibody?

RRID-verified. Application checked. We'll connect you with the right supplier.

Request Quote

All products RRID-verified through the Antibody Registry. Application and species data from supplier specifications and published research. No paid placements.

Last updated: August 2026